From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy Morvane ColinSimon DujardinLuc Buée Review Open access 04 November 2019 Pages: 3 - 25
Evidence of corticofugal tau spreading in patients with frontotemporal dementia Eun-Joo KimJi-Hye L. HwangWilliam W. Seeley Original Paper 21 September 2019 Pages: 27 - 43
The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion Zeran LiFabiana H. G. FariasCarlos Cruchaga Original Paper 27 August 2019 Pages: 45 - 61
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration Eri SaijoMichael A. Metrick IIByron Caughey Original Paper 16 October 2019 Pages: 63 - 77
Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration Eri SaijoMichael A. Metrick IIByron Caughey Correction 20 November 2019 Pages: 79 - 81
Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases Ian R. MackenzieManuela Neumann Original Paper 09 September 2019 Pages: 83 - 98
Poly-glycine–alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3 Yoshihiro NiheiKohji MoriChristian Haass Original Paper Open access 23 October 2019 Pages: 99 - 118
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis Patrick OecklPatrick WeydtMarkus Otto Original Paper 07 November 2019 Pages: 119 - 134
White matter DNA methylation profiling reveals deregulation of HIP1, LMAN2, MOBP, and other loci in multiple system atrophy Conceição BettencourtSandrine C. FotiJanice L. Holton Original Paper Open access 18 September 2019 Pages: 135 - 156
NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation Yanan YuKwangmin ChoiNancy Ratner Original Paper 29 October 2019 Pages: 157 - 174
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas Frank BrandAlisa FörsterRuthild G. Weber Original Paper 31 August 2019 Pages: 175 - 192
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course Annika K. WefersDamian StichelDavid Capper Original Paper 28 September 2019 Pages: 193 - 209
Histone epiproteomic profiling distinguishes oligodendroglioma, IDH-mutant and 1p/19q co-deleted from IDH-mutant astrocytoma and reveals less tri-methylation of H3K27 in oligodendrogliomas C. FellerM. FelixD. E. Reuss Correspondence 26 November 2019 Pages: 211 - 213
YAP1-fusions in pediatric NF2-wildtype meningioma Philipp SieversJason ChiangFelix Sahm Correspondence 16 November 2019 Pages: 215 - 218
Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls Daniel ErskineAmy K. ReeveYi Shau Ng Correspondence Open access 28 November 2019 Pages: 219 - 221
